Establishing a Framework for the Use of Social Media in Pharmacovigilance in Europe Sabine BroschAnne-Marie de FerranPhil Tregunno Special Article Open access 30 March 2019 Pages: 921 - 930
Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error Classification (HAMEC) Peter J. GatesMelissa T. BaysariJohanna I. Westbrook Leading Article Open access 23 April 2019 Pages: 931 - 939
Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis Babak SoleimaniKaty MurrayDavid Hunt Review Article 04 March 2019 Pages: 941 - 956
Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists Rasmus M. ChristensenChristian R. JuhlSigne S. Torekov Review Article 10 April 2019 Pages: 957 - 971
Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances Teresa Bellón Review Article 24 April 2019 Pages: 973 - 992
Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study Estelle GuiardBénédicte LelievrePatrick Blin Original Research Article 08 May 2019 Pages: 993 - 1003
Androgen Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-Based Cohort Study Adi J. Klil-DroriChristina SantellaLaurent Azoulay Original Research Article 25 June 2019 Pages: 1005 - 1011
Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study Paul K. WinnerAndrew M. BlumenfeldMitchell F. Brin Original Research Article Open access 17 May 2019 Pages: 1013 - 1024